Doxorubicin cardiotoxicity: Prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era
- 1 March 2003
- journal article
- research article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 10 (2) , 132-139
- https://doi.org/10.1067/mnc.2003.7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cardiotoxicity of doxorubicin and other anthracycline derivativesJournal of Nuclear Cardiology, 2000
- Outcomes and costs within a disease management program for advanced congestive heart failureAmerican Heart Journal, 1998
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995
- Dexrazoxane in the Prevention of Doxorubicin-Induced CardiotoxicityAnnals of Pharmacotherapy, 1994
- Doxorubicin cardiotoxicity: analysis of prevailing hypothesesThe FASEB Journal, 1990
- Antineoplastic Drugs in 1990Drugs, 1990
- Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapyThe American Journal of Medicine, 1987
- A MODIFIED METHOD FOR THE INVIVO LABELING OF RED-BLOOD-CELLS WITH TC-99M - CONCISE COMMUNICATION1982
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979